Alteration of host protein stability by Legionella

军团菌改变宿主蛋白稳定性

基本信息

  • 批准号:
    8268377
  • 负责人:
  • 金额:
    $ 21.19万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-06-01 至 2013-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Infection with the intracellular pathogen Legionella pneumophila can lead to a severe pneumonia known as Legionnaires' disease. Legionella pneumophila uses a specialized type IV secretion apparatus, also known as the Dot/Icm system, to secrete over 150 effector proteins directly into the host cell. The translocated bacterial effectors establish a vacuolar niche that supports replication of L. pneumophila in eukaryotic cells. While there is an extensive literature describing how several of these effectors alter host cell functions, the targets of most have remained elusive. A significant problem in linking a particular effector to a particular function is the redundant or overlapping activity of many effectors. This means that L. pneumophila mutant strains deficient in any one effector often have no appreciable phenotype, preventing the identification of their host targets. While it is well appreciated that many L. pneumophila effectors directly alter host proteins through functions such as E3 ubiquitin ligase activity, there have been few methods developed to monitor pathogen-induced changes in host protein stability on a large scale. Here we propose to apply a novel screening method called the "Global Protein Stability" (GPS) system to identify host cell proteins whose stability is altered by the secreted L. pneumophila effectors. Once we have identified host proteins that are stabilized or destabilized when a functional type IV secretion system is present, we will test whether reducing or increasing the prevalence of these proteins (attempting to reverse the effects of the Legionella effectors) impairs the capacity of L. pneumophila to replicate and survive within host cells. Once we identify which host proteins must be altered in order for L. pneumophila to replicate, we will take a targeted approach to identify which of the L. pneumophila effectors are causing these essential changes to host proteins. In addition, the GPS screen may also identify the targets of specific "families" of effectors that have remained elusive, such as the L. pneumophila E3 ubiquitin ligases. The directed approach we propose allows us to overcome the difficulties inherent in target identification, such as the redundancy of effectors, and identify the functions of effectors that have remained cryptic. Organism-induced alterations of the host are key to pathogenesis, yet it has previously not been possible to study alterations to individual host proteins at the scale the GPS system permits. The experiments described in this proposal allow, for the first time, dissection of how bacterial infection globally regulates host cell proteins and pathways beyond the transcriptional level.
描述(由申请人提供):细胞内病原体肺炎的感染可导致严重的肺炎被称为军团疾病。肺炎军团使用专门的IV型分泌设备,也称为DOT/ICM系统,将150多种效应蛋白直接分泌到宿主细胞中。易位的细菌效应子建立了一个液泡生态位,该泡酸盐支持真核细胞中肺炎乳杆菌的复制。尽管有广泛的文献描述了这些效应器中的几个如何改变宿主细胞功能,但大多数效应的目标仍然难以捉摸。将特定效应子与特定功能联系起来的一个重要问题是许多效应子的冗余或重叠活动。这意味着任何一种效应子缺乏的肺炎乳杆菌菌株通常没有明显的表型,从而阻止了其宿主靶标的识别。虽然许多肺炎乳杆菌效应子通过诸如E3泛素连接酶活性直接改变宿主蛋白的众所周知,但几乎没有开发用于监测病原体诱导的大规模宿主蛋白稳定性变化的方法。在这里,我们建议采用一种称为“全局蛋白质稳定性”(GPS)系统的新型筛选方法来识别宿主细胞蛋白,其稳定性被分泌的肺炎乳杆菌效应子改变。一旦我们确定了存在IV型功能性分泌系统时稳定或不稳定的宿主蛋白,我们将测试是否会降低或增加这些蛋白质的患病率(试图逆转军团菌效应子的影响)会损害肺炎乳杆菌的能力,以复制和在宿主细胞内生存。一旦我们确定了必须改变哪种宿主蛋白​​才能复制肺炎乳杆菌,我们将采用靶向方法来识别哪些肺炎乳杆菌效应子正在导致宿主蛋白的这些基本变化。此外,GPS屏幕还可以识别出仍然难以捉摸的特定效应子的靶标,例如肺炎乳杆菌E3泛素连接酶。我们提出的定向方法使我们能够克服目标识别固有的困难,例如效应子的冗余,并确定效应子的功能仍然是隐秘的。生物体诱导的宿主改变是发病机理的关键,但以前无法在GPS系统允许的规模上研究对单个宿主蛋白的改变。该提案中描述的实验首次允许对全球细菌感染的解剖如何调节宿主细胞蛋白和转录水平的途径。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL N STARNBACH其他文献

MICHAEL N STARNBACH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL N STARNBACH', 18)}}的其他基金

Identifying Chlamydia trachomatis factors that mediate PD-L1 upregulation
鉴定介导 PD-L1 上调的沙眼衣原体因子
  • 批准号:
    10724569
  • 财政年份:
    2023
  • 资助金额:
    $ 21.19万
  • 项目类别:
Interferon gamma-mediated restriction of Shigella flexneri replication
干扰素γ介导的福氏志贺氏菌复制限制
  • 批准号:
    8495255
  • 财政年份:
    2012
  • 资助金额:
    $ 21.19万
  • 项目类别:
Interferon gamma-mediated restriction of Shigella flexneri replication
干扰素γ介导的福氏志贺氏菌复制限制
  • 批准号:
    8385347
  • 财政年份:
    2012
  • 资助金额:
    $ 21.19万
  • 项目类别:
Alteration of host protein stability by Legionella
军团菌改变宿主蛋白稳定性
  • 批准号:
    8176583
  • 财政年份:
    2011
  • 资助金额:
    $ 21.19万
  • 项目类别:
2009 Gordon Conference on Microbial Adhesion and Signal Transduction
2009 年戈登微生物粘附和信号转导会议
  • 批准号:
    7743610
  • 财政年份:
    2009
  • 资助金额:
    $ 21.19万
  • 项目类别:
Factors Mediating Host Resistance to Chlamydia trachomatis
介导宿主对沙眼衣原体抵抗力的因素
  • 批准号:
    8186804
  • 财政年份:
    2006
  • 资助金额:
    $ 21.19万
  • 项目类别:
Genetics of Host Resistance to Chlamydia trachomatis
宿主对沙眼衣原体抗性的遗传学
  • 批准号:
    7174281
  • 财政年份:
    2006
  • 资助金额:
    $ 21.19万
  • 项目类别:
Factors Mediating Host Resistance to Chlamydia trachomatis
介导宿主对沙眼衣原体抵抗力的因素
  • 批准号:
    8695275
  • 财政年份:
    2006
  • 资助金额:
    $ 21.19万
  • 项目类别:
Factors Mediating Host Resistance to Chlamydia trachomatis
介导宿主对沙眼衣原体抵抗力的因素
  • 批准号:
    8288686
  • 财政年份:
    2006
  • 资助金额:
    $ 21.19万
  • 项目类别:
Genetics of Host Resistance to Chlamydia trachomatis
宿主对沙眼衣原体抗性的遗传学
  • 批准号:
    7559667
  • 财政年份:
    2006
  • 资助金额:
    $ 21.19万
  • 项目类别:

相似国自然基金

基于抗生素-AIE探针的细菌胞外囊泡检测新方法的构建及其在血流感染中的应用价值研究
  • 批准号:
    82272438
  • 批准年份:
    2022
  • 资助金额:
    52.00 万元
  • 项目类别:
    面上项目
基于抗生素-AIE探针的细菌胞外囊泡检测新方法的构建及其在血流感染中的应用价值研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
以活性为导向的硫肽类抗生素的衍生及其在口腔细菌感染性疾病中的应用研究
  • 批准号:
    81974495
  • 批准年份:
    2019
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
基于免疫调节发掘有毒动物来源天然多肽抗耐药胞内细菌感染
  • 批准号:
    81872839
  • 批准年份:
    2018
  • 资助金额:
    57.0 万元
  • 项目类别:
    面上项目
细菌响应抗生素释放系统的建立及对骨感染病灶的靶向治疗作用研究
  • 批准号:
    81802178
  • 批准年份:
    2018
  • 资助金额:
    21.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Thiazolino-Pyridone Compounds as Novel Drugs for Tuberculosis
噻唑啉-吡啶酮化合物作为结核病新药
  • 批准号:
    10698829
  • 财政年份:
    2023
  • 资助金额:
    $ 21.19万
  • 项目类别:
Brewing anti-toxin drugs using probiotic yeast
利用益生菌酵母酿造抗毒素药物
  • 批准号:
    10687670
  • 财政年份:
    2023
  • 资助金额:
    $ 21.19万
  • 项目类别:
Highly Acidifying Intravaginal Rings with Lactobacillus Probiotics to Treat Bacterial Vaginosis
含乳酸菌益生菌的高度酸化阴道环可治疗细菌性阴道病
  • 批准号:
    10699458
  • 财政年份:
    2023
  • 资助金额:
    $ 21.19万
  • 项目类别:
On Demand Dissoluble Supramolecular Hydrogels: Towards Pain Free Burn Dressings
按需可溶性超分子水凝胶:迈向无痛烧伤敷料
  • 批准号:
    10658220
  • 财政年份:
    2023
  • 资助金额:
    $ 21.19万
  • 项目类别:
Antifungal discovery from previously uncultivated bacteria
从以前未培养的细菌中发现抗真菌药物
  • 批准号:
    10693593
  • 财政年份:
    2023
  • 资助金额:
    $ 21.19万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了